Toggle light / dark theme

Multiply Labs Announces $20 Million Series A to Pioneer Robotic Manufacturing of Individualized Drugs

Multiply Labs, a robotics company developing automated systems for the production of individualized drugs, announced that it raised its Series A.

Leave a Comment

If you are already a member, you can use this form to update your payment info.

Lifeboat Foundation respects your privacy! Your email address will not be published.